In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an...

Since March of 2020, COVID-19 changed most aspects of life as we knew it, from our personal day-to-day activities to the systems, processes, and structures that keep the global economy interconnected and moving. This included pharmaceutical production and distribution, where anecdotal evidence ...

Today we launch an interactive tool that analyses the COVID-19 vaccine portfolio, and generates estimates about the timelines for the vaccines in the portfolio.

Building on recommendations from leading experts in governments, academia, and industry, the Center for Global Development and Ariadne Labs have created a tool to estimate vaccine success in a variety of scenarios. By giving inputs on timelines and the estimated probability of success for different ...

If governments of LMICs reformed their medicines procurement practices, how much money would they be able to save? And how much further towards universal health coverage would these savings enable them to go?